• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人卵巢癌模型中,协调的蛋白质模块以单细胞分辨率定义了对卡铂的DNA损伤反应。

Coordinated protein modules define DNA damage responses to carboplatin at single cell resolution in human ovarian carcinoma models.

作者信息

Bedia Jacob S, Huang Ying-Wen, Gonzalez Antonio Delgado, Gonzalez Veronica D, Funingana Ionut-Gabriel, Rahil Zainab, Mike Alyssa, Lowber Alexis, Vias Maria, Ashworth Alan, Brenton James D, Fantl Wendy J

机构信息

Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

bioRxiv. 2024 Nov 26:2024.11.21.624591. doi: 10.1101/2024.11.21.624591.

DOI:10.1101/2024.11.21.624591
PMID:39605494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11601625/
Abstract

Tubo-ovarian high-grade serous carcinoma (HGSC) is the most lethal gynecological malignancy and frequently responds to platinum-based chemotherapy because of common genetic and somatic impairment of DNA damage repair (DDR) pathways. The mechanisms of clinical platinum resistance are diverse and poorly molecularly defined. Consequently, there are no biomarkers or medicines that improve patient outcomes. Herein we use single cell mass cytometry (CyTOF) to systematically evaluate the phosphorylation and abundance of proteins known to participate in the DNA damage response (DDR). Single cell analyses of highly characterized HGSC cell lines that phenocopy human patients show that cells with comparable levels of intranuclear platinum, a proxy for carboplatin uptake, undergo different cell fates. Unsupervised analyses revealed a continuum of DDR responses. Decompositional methods were used to identify eight distinct protein modules of carboplatin resistance and sensitivity at single cell resolution. CyTOF profiling of primary and secondary platinum-resistance patient models shows that a complex DDR sensitivity module is strongly associated with response, suggesting it as a potential tool to clinically characterize complex drug resistance phenotypes.

摘要

输卵管卵巢高级别浆液性癌(HGSC)是最致命的妇科恶性肿瘤,由于DNA损伤修复(DDR)途径常见的基因和体细胞损伤,其对铂类化疗常常有反应。临床铂耐药的机制多种多样,且分子层面定义不明确。因此,没有生物标志物或药物能改善患者预后。在此,我们使用单细胞质谱流式细胞术(CyTOF)系统评估已知参与DNA损伤反应(DDR)的蛋白质的磷酸化和丰度。对高度特征化的、模拟人类患者的HGSC细胞系进行单细胞分析表明,具有可比核内铂水平(卡铂摄取的替代指标)的细胞会经历不同的细胞命运。无监督分析揭示了DDR反应的连续性。采用分解方法在单细胞分辨率下识别出八个不同的卡铂耐药和敏感蛋白模块。对原发性和继发性铂耐药患者模型的CyTOF分析表明,一个复杂的DDR敏感模块与反应密切相关,这表明它是临床上表征复杂耐药表型的潜在工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2848/11601625/3c8d54248946/nihpp-2024.11.21.624591v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2848/11601625/d507737edb18/nihpp-2024.11.21.624591v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2848/11601625/3c8d54248946/nihpp-2024.11.21.624591v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2848/11601625/d507737edb18/nihpp-2024.11.21.624591v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2848/11601625/3c8d54248946/nihpp-2024.11.21.624591v2-f0004.jpg

相似文献

1
Coordinated protein modules define DNA damage responses to carboplatin at single cell resolution in human ovarian carcinoma models.在人卵巢癌模型中,协调的蛋白质模块以单细胞分辨率定义了对卡铂的DNA损伤反应。
bioRxiv. 2024 Nov 26:2024.11.21.624591. doi: 10.1101/2024.11.21.624591.
2
Coordinated protein modules define DNA damage responses to carboplatin at single-cell resolution in human ovarian carcinoma models.在人类卵巢癌模型中,协调的蛋白质模块在单细胞分辨率下定义了对卡铂的DNA损伤反应。
Cell Rep Med. 2025 Sep 16;6(9):102295. doi: 10.1016/j.xcrm.2025.102295. Epub 2025 Aug 22.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
5
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.聚(ADP-核糖)聚合酶(PARP)抑制剂治疗卵巢癌。
Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4.
6
A systematic overview of chemotherapy effects in ovarian cancer.卵巢癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420.
7
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms.靶向COP9信号体通过两种不同的基因组稳定性机制克服卵巢癌中的铂耐药性。
bioRxiv. 2025 Aug 6:2025.08.04.668450. doi: 10.1101/2025.08.04.668450.
8
Organoid Models Established from Primary Tumors and Patient-Derived Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients.从原发性肿瘤和患者来源的异种移植肿瘤建立的类器官模型反映了卵巢癌患者的铂敏感性。
bioRxiv. 2025 May 2:2024.06.28.601283. doi: 10.1101/2024.06.28.601283.
9
Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models.卵巢癌细胞系和同基因模型中的细胞内在铂反应以及相关的遗传和基因表达特征。
bioRxiv. 2024 Jul 29:2024.07.26.605381. doi: 10.1101/2024.07.26.605381.
10
Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的医学干预措施。
Cochrane Database Syst Rev. 2014 Jul 1(7):CD009219. doi: 10.1002/14651858.CD009219.pub3.

本文引用的文献

1
Cellular adaptation to cancer therapy along a resistance continuum.细胞沿着抵抗连续体适应癌症治疗。
Nature. 2024 Jul;631(8022):876-883. doi: 10.1038/s41586-024-07690-9. Epub 2024 Jul 10.
2
Clinical and molecular features of platinum resistance in ovarian cancer.卵巢癌铂耐药的临床和分子特征。
Crit Rev Oncol Hematol. 2024 Sep;201:104434. doi: 10.1016/j.critrevonc.2024.104434. Epub 2024 Jul 1.
3
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.复发性卵巢高级别浆液性癌的拷贝数和突变特征。
Nat Commun. 2023 Jul 20;14(1):4387. doi: 10.1038/s41467-023-39867-7.
4
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative Review.卵巢癌治疗的进展和铂耐药患者的未满足治疗需求:叙述性综述。
JAMA Oncol. 2023 Jun 1;9(6):851-859. doi: 10.1001/jamaoncol.2023.0197.
5
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.同源重组缺陷型晚期高级别浆液性卵巢癌的多组学分析
Nat Genet. 2023 Mar;55(3):437-450. doi: 10.1038/s41588-023-01320-2. Epub 2023 Feb 27.
6
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors.多参数单细胞蛋白质组学技术为卵巢肿瘤的生物学研究提供了新的见解。
Semin Immunopathol. 2023 Jan;45(1):43-59. doi: 10.1007/s00281-022-00979-9. Epub 2023 Jan 12.
7
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer.卵巢癌中逐步获得卡铂耐药性的单细胞特征分析。
NPJ Syst Biol Appl. 2022 Jun 17;8(1):20. doi: 10.1038/s41540-022-00230-z.
8
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer.耐药性:癌症中靶向治疗的适应性反应所带来的机遇。
Nat Rev Cancer. 2022 Jun;22(6):323-339. doi: 10.1038/s41568-022-00454-5. Epub 2022 Mar 9.
9
Mass Cytometry for the Characterization of Individual Cell Types in Ovarian Solid Tumors.利用液质联用技术对卵巢实体瘤中单个细胞类型进行特征分析。
Methods Mol Biol. 2022;2424:59-94. doi: 10.1007/978-1-0716-1956-8_4.
10
TP53 loss initiates chromosomal instability in fallopian tube epithelial cells.TP53 缺失导致输卵管上皮细胞的染色体不稳定。
Dis Model Mech. 2021 Nov 1;14(11). doi: 10.1242/dmm.049001. Epub 2021 Nov 30.